Diameter Capital Partners’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-47,200
Closed -$473K 141
2021
Q2
$473K Sell
47,200
-664,572
-93% -$6.72M 0.03% 124
2021
Q1
$7.15M Buy
+711,772
New +$7.57M 0.75% 28

Other funds holding MTACU

Diameter Capital Partners's MTACU Position: Q3 2021 in Review

Diameter Capital Partners sold out of MedTech Acquisition Corporation Unit (MTACU) in Q3 2021, closing a stake of 47,200 shares — an estimated $473K sold.

Diameter Capital Partners first reported a position in MTACU in Q1 2021 and held it in 2 quarters. The position peaked at $7.15M in Q1 2021. 20 funds tracked by Wall St. Rank hold MTACU as of Q3 2021.

  • Diameter Capital Partners reported no remaining MedTech Acquisition Corporation Unit position as of Q3 2021 after selling out during the quarter.
  • Diameter Capital Partners sold 47,200 MedTech Acquisition Corporation Unit shares in Q3 2021, an estimated $473K.
  • Diameter Capital Partners first reported a position in MedTech Acquisition Corporation Unit in Q1 2021 and held it in 2 quarters.
  • Diameter Capital Partners's MedTech Acquisition Corporation Unit position peaked at $7.15M in Q1 2021.
  • 20 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q3 2021.

Based on Diameter Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.